<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38298902</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2666-3546</ISSN><JournalIssue CitedMedium="Internet"><Volume>36</Volume><PubDate><Year>2024</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Brain, behavior, &amp; immunity - health</Title><ISOAbbreviation>Brain Behav Immun Health</ISOAbbreviation></Journal><ArticleTitle>Associations between COVID-19 and putative markers of neuroinflammation: A diffusion basis spectrum imaging study.</ArticleTitle><Pagination><StartPage>100722</StartPage><MedlinePgn>100722</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">100722</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bbih.2023.100722</ELocationID><Abstract><AbstractText>COVID-19 remains a significant international public health concern. Yet, the mechanisms through which symptomatology emerges remain poorly understood. While SARS-CoV-2 infection may induce prolonged inflammation within the central nervous system, the evidence primarily stems from limited small-scale case investigations. To address this gap, our study capitalized on longitudinal UK Biobank neuroimaging data acquired prior to and following COVID-19 testing (N&#xa0;=&#xa0;416 including n&#xa0;=&#xa0;224 COVID-19 cases; M<sub>age</sub>&#xa0;=&#xa0;58.6). Putative neuroinflammation was assessed in gray matter structures and white matter tracts using non-invasive Diffusion Basis Spectrum Imaging (DBSI), which estimates inflammation-related cellularity (DBSI-restricted fraction; DBSI-RF) and vasogenic edema (DBSI-hindered fraction; DBSI-HF). We hypothesized that COVID-19 case status would be associated with increases in DBSI markers after accounting for potential confound (age, sex, race, body mass index, smoking frequency, and data acquisition interval) and multiple testing. COVID-19 case status was not significantly associated with DBSI-RF (|&#x3b2;|'s&#xa0;&lt;&#xa0;0.28, p<sub>FDR</sub> &gt;0.05), but with greater DBSI-HF in left pre- and post-central gyri and right middle frontal gyrus (&#x3b2;'s&#xa0;&gt;&#xa0;0.3, all p<sub>FDR</sub>&#xa0;=&#xa0;0.03). Intriguingly, the brain areas exhibiting increased putative vasogenic edema had previously been linked to COVID-19-related functional and structural alterations, whereas brain regions displaying subtle differences in cellularity between COVID-19 cases and controls included regions within or functionally connected to the olfactory network, which has been implicated in COVID-19 psychopathology. Nevertheless, our study might not have captured acute and transitory neuroinflammatory effects linked to SARS-CoV-2 infection, possibly due to symptom resolution before the imaging scan. Future research is warranted to explore the potential time- and symptom-dependent neuroinflammatory relationship with COVID-19.</AbstractText><CopyrightInformation>&#xa9; 2024 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gorelik</LastName><ForeName>Aaron J</ForeName><Initials>AJ</Initials><AffiliationInfo><Affiliation>Department of Psychological &amp; Brain Sciences, Washington University, St. Louis, MO, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Qing</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Norton</LastName><ForeName>Sara A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Department of Psychological &amp; Brain Sciences, Washington University, St. Louis, MO, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hershey</LastName><ForeName>Tamara</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychological &amp; Brain Sciences, Washington University, St. Louis, MO, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Washington University School of Medicine, St. Louis, MO, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agrawal</LastName><ForeName>Arpana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bijsterbosch</LastName><ForeName>Janine D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bogdan</LastName><ForeName>Ryan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Psychological &amp; Brain Sciences, Washington University, St. Louis, MO, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Brain Behav Immun Health</MedlineTA><NlmUniqueID>101759062</NlmUniqueID><ISSNLinking>2666-3546</ISSNLinking></MedlineJournalInfo><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>bioRxiv. 2023 Dec 27:2023.07.20.549891. doi: 10.1101/2023.07.20.549891</RefSource><PMID Version="1">37502886</PMID></CommentsCorrections></CommentsCorrectionsList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">DBSI</Keyword><Keyword MajorTopicYN="N">Diffusion basis spectrum imaging</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Neuroimaging</Keyword><Keyword MajorTopicYN="N">Neuroinflammation</Keyword><Keyword MajorTopicYN="N">UK biobank</Keyword></KeywordList><CoiStatement>The authors have no conflicts of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>12</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>1</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>1</Day><Hour>4</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38298902</ArticleId><ArticleId IdType="pmc">PMC10825665</ArticleId><ArticleId IdType="doi">10.1016/j.bbih.2023.100722</ArticleId><ArticleId IdType="pii">S2666-3546(23)00136-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Akinbami L.J.  2021. SARS-CoV-2 Serology and Self-Reported Infection Among Adults &#x2014; National Health and Nutrition Examination Survey, United States.https://www.cdc.gov/mmwr/volumes/71/wr/mm7148a4.htm MMWR Morb Mortal Wkly Rep [Internet]. 2022 [cited 2023 Jun 20];71. Available from:</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9721142</ArticleId><ArticleId IdType="pubmed">36454698</ArticleId></ArticleIdList></Reference><Reference><Citation>Alfaro-Almagro F., Jenkinson M., Bangerter N.K., Andersson J.L.R., Griffanti L., Douaud G., et al. Image processing and Quality Control for the first 10,000 brain imaging datasets from UK Biobank. Neuroimage. 2018;166:400&#x2013;424.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5770339</ArticleId><ArticleId IdType="pubmed">29079522</ArticleId></ArticleIdList></Reference><Reference><Citation>Baj J., Karaku&#x142;a-Juchnowicz H., Teresi&#x144;ski G., Buszewicz G., Ciesielka M., Sitarz R., et al. COVID-19: specific and non-specific clinical manifestations and symptoms: the current state of knowledge. J. Clin. Med. 2020;9(6):1753.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7356953</ArticleId><ArticleId IdType="pubmed">32516940</ArticleId></ArticleIdList></Reference><Reference><Citation>Bispo DD. de C., Brand&#xe3;o PR. de P., Pereira D.A., Maluf F.B., Dias B.A., Paranhos H.R., et al. Brain microstructural changes and fatigue after COVID-19. Front. Neurol. 2022;13</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9685991</ArticleId><ArticleId IdType="pubmed">36438956</ArticleId></ArticleIdList></Reference><Reference><Citation>Boroujeni M.E., Simani L., Bluyssen H.A.R., Samadikhah H.R., Zamanlui Benisi S., Hassani S., et al. Inflammatory response leads to neuronal death in human post-mortem cerebral cortex in patients with COVID-19. ACS Chem. Neurosci. 2021;12(12):2143&#x2013;2150.</Citation><ArticleIdList><ArticleId IdType="pubmed">34100287</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouayed J., Bohn T. The link between microglia and the severity of COVID-19: the &#x201c;two-hit&#x201d; hypothesis. J. Med. Virol. 2021;93(7):4111&#x2013;4113.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8250886</ArticleId><ArticleId IdType="pubmed">33788265</ArticleId></ArticleIdList></Reference><Reference><Citation>Braga J., Lepra M., Kish S.J., PabloM Rusjan, Nasser Z., Verhoeff N., et al. Neuroinflammation after COVID-19 with persistent depressive and cognitive symptoms. JAMA Psychiatr. 2023 doi: 10.1001/jamapsychiatry.2023.1321. [Internet]</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2023.1321</ArticleId><ArticleId IdType="pmc">PMC10233457</ArticleId><ArticleId IdType="pubmed">37256580</ArticleId></ArticleIdList></Reference><Reference><Citation>Brann D.H., Tsukahara T., Weinreb C., Lipovsek M., Van den Berge K., Gong B., et al. Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. Sci. Adv. 2020;6(31)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10715684</ArticleId><ArticleId IdType="pubmed">32937591</ArticleId></ArticleIdList></Reference><Reference><Citation>Brusaferri L., Alshelh Z., Martins D., Kim M., Weerasekera A., Housman H., et al. The pandemic brain: neuroinflammation in non-infected individuals during the COVID-19 pandemic. Brain Behav. Immun. 2022;102:89&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8847082</ArticleId><ArticleId IdType="pubmed">35181440</ArticleId></ArticleIdList></Reference><Reference><Citation>Butowt R., Bilinska K. SARS-CoV-2: olfaction, brain infection, and the urgent need for clinical samples allowing earlier virus detection. ACS Chem. Neurosci. 2020;11(9):1200&#x2013;1203.</Citation><ArticleIdList><ArticleId IdType="pubmed">32283006</ArticleId></ArticleIdList></Reference><Reference><Citation>Channappanavar R., Perlman S. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin. Immunopathol. 2017;39(5):529&#x2013;539.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7079893</ArticleId><ArticleId IdType="pubmed">28466096</ArticleId></ArticleIdList></Reference><Reference><Citation>Chasco E.E., Dukes K., Jones D., Comellas A.P., Hoffman R.M., Garg A. Brain fog and fatigue following COVID-19 infection: an exploratory study of patient experiences of long COVID. Int. J. Environ. Res. Publ. Health. 2022;19(23)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9737348</ArticleId><ArticleId IdType="pubmed">36497573</ArticleId></ArticleIdList></Reference><Reference><Citation>Cross A.H., Song S.K. A new imaging modality to non-invasively assess multiple sclerosis pathology. J. Neuroimmunol. 2017;304:81&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5316501</ArticleId><ArticleId IdType="pubmed">27773433</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutler, David M. The Economic Cost of Long COVID: An Update [Internet]. [cited 2023 Aug 28]. Available from: https://scholar.harvard.edu/files/cutler/files/long_covid_update_7-22.pdf.</Citation></Reference><Reference><Citation>Cutler D.M. The costs of long COVID. JAMA Health Forum. 2022;3(5)</Citation><ArticleIdList><ArticleId IdType="pubmed">36219031</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalby T., Wohl E., Dinsmore M., Unger Z., Chowdhury T., Venkatraghavan L. Pathophysiology of cerebral edema&#x2014;a comprehensive review. J Neuroanaesth Crit Care. 2021;8(3):163&#x2013;172.</Citation></Reference><Reference><Citation>Darif D., Hammi I., Kihel A., El Idrissi Saik I., Guessous F., Akarid K. The pro-inflammatory cytokines in COVID-19 pathogenesis: what goes wrong? Microb. Pathog. 2021;153</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7889464</ArticleId><ArticleId IdType="pubmed">33609650</ArticleId></ArticleIdList></Reference><Reference><Citation>Desikan R.S., S&#xe9;gonne F., Fischl B., Quinn B.T., Dickerson B.C., Blacker D., et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage. 2006;31(3):968&#x2013;980.</Citation><ArticleIdList><ArticleId IdType="pubmed">16530430</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G., Lee S., Alfaro-Almagro F., Arthofer C., Wang C., McCarthy P., et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022;604(7907):697&#x2013;707.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Y.Y., Zhao W., Zhou X.L., Zeng M., Yang D.H., Xie X.Z., et al. Survivors of COVID-19 exhibit altered amplitudes of low frequency fluctuation in the brain: a resting-state functional magnetic resonance imaging study at 1-year follow-up. Neural Regeneration Research. 2022;17(7):1576.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8771089</ArticleId><ArticleId IdType="pubmed">34916443</ArticleId></ArticleIdList></Reference><Reference><Citation>Farhadian S., Glick L.R., Vogels C.B.F., Thomas J., Chiarella J., Casanovas-Massana A., et al. Acute encephalopathy with elevated CSF inflammatory markers as the initial presentation of COVID-19. BMC Neurol. 2020;20(1):248.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7301053</ArticleId><ArticleId IdType="pubmed">32552792</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischl B., Salat D.H., Busa E., Albert M., Dieterich M., Haselgrove C., et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron. 2002;33(3):341&#x2013;355.</Citation><ArticleIdList><ArticleId IdType="pubmed">11832223</ArticleId></ArticleIdList></Reference><Reference><Citation>Frere J.J., Serafini R.A., Pryce K.D., Zazhytska M., Oishi K., Golynker I., et al. SARS-CoV-2 infection in hamsters and humans results in lasting and unique systemic perturbations after recovery. Sci. Transl. Med. 2022;14(664)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9210449</ArticleId><ArticleId IdType="pubmed">35857629</ArticleId></ArticleIdList></Reference><Reference><Citation>Fry A., Littlejohns T.J., Sudlow C., Doherty N., Adamska L., Sprosen T., et al. Comparison of sociodemographic and health-related characteristics of UK Biobank participants with those of the general population. Am. J. Epidemiol. 2017;186(9):1026&#x2013;1034.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5860371</ArticleId><ArticleId IdType="pubmed">28641372</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu Z., Tu Y., Calhoun V.D., Zhang Y., Zhao Q., Chen J., et al. Dynamic functional network connectivity associated with post-traumatic stress symptoms in COVID-19 survivors. Neurobiology of Stress. 2021;15</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8339567</ArticleId><ArticleId IdType="pubmed">34377750</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497&#x2013;506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S., Zhou Z., Yang D., Zhao W., Zeng M., Xie X., et al. Persistent white matter changes in recovered COVID-19 patients at the 1-year follow-up. Brain. 2021;145(5):1830&#x2013;1838.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8754808</ArticleId><ArticleId IdType="pubmed">34918020</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S., Zhou X., Zhao W., Du Y., Yang D., Huang Y., et al. Dynamic white matter changes in recovered COVID-19 patients: a two-year follow-up study. Theranostics. 2023;13(2):724&#x2013;735.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9830428</ArticleId><ArticleId IdType="pubmed">36632218</ArticleId></ArticleIdList></Reference><Reference><Citation>Isasi F., Naylor M.D., Skorton D., Grabowski D.C., Hern&#xe1;ndez S., Rice V.M. Patients, families, and communities COVID-19 impact assessment: lessons learned and compelling needs. NAM Perspect. 2021 doi: 10.31478/202111c.</Citation><ArticleIdList><ArticleId IdType="doi">10.31478/202111c</ArticleId><ArticleId IdType="pmc">PMC8803391</ArticleId><ArticleId IdType="pubmed">35118349</ArticleId></ArticleIdList></Reference><Reference><Citation>Janelle F., Iorio-Morin C., D&#x2019;amour S., Fortin D. Superior longitudinal fasciculus: a review of the anatomical descriptions with functional correlates. Front. Neurol. 2022;13</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9093186</ArticleId><ArticleId IdType="pubmed">35572948</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong G.U., Lyu J., Kim K.D., Chung Y.C., Yoon G.Y., Lee S., et al. SARS-CoV-2 infection of microglia elicits proinflammatory activation and apoptotic cell death. Microbiol. Spectr. 2022;10(3)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9241873</ArticleId><ArticleId IdType="pubmed">35510852</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeurissen B., Tournier J.D., Dhollander T., Connelly A., Sijbers J. Multi-tissue constrained spherical deconvolution for improved analysis of multi-shell diffusion MRI data. Neuroimage. 2014;103:411&#x2013;426.</Citation><ArticleIdList><ArticleId IdType="pubmed">25109526</ArticleId></ArticleIdList></Reference><Reference><Citation>Kafali H.Y., Dasgin H., Sahin D., Sozan S.S., Oguz K.K., Mutlu M., et al. The effect of SARS-CoV-2 virus on resting-state functional connectivity during adolescence: investigating brain correlates of psychotic-like experiences and SARS-CoV-2 related inflammation response. Psychiatr. Res. Neuroimaging. 2023</Citation><ArticleIdList><ArticleId IdType="pubmed">37979347</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanberg N., Simr&#xe9;n J., Ed&#xe9;n A., Andersson L.M., Nilsson S., Ashton N.J., et al. Neurochemical signs of astrocytic and neuronal injury in acute COVID-19 normalizes during long-term follow-up. EBioMedicine. 2021;70</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8320425</ArticleId><ArticleId IdType="pubmed">34333238</ArticleId></ArticleIdList></Reference><Reference><Citation>Krasemann S., Haferkamp U., Pfefferle S., Woo M.S., Heinrich F., Schweizer M., et al. The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2. Stem Cell Rep. 2022;17(2):307&#x2013;320.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8772030</ArticleId><ArticleId IdType="pubmed">35063125</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar P.R., Shilpa B., Jha R.K. Brain disorders: impact of mild SARS-CoV-2 may shrink several parts of the brain. Neurosci. Biobehav. Rev. 2023;149</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10063523</ArticleId><ArticleId IdType="pubmed">37004892</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C., Martins A.J., Lau W.W., Rachmaninoff N., Chen J., Imberti L., et al. Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19. Cell. 2021;184(7) 1836-1857.e22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7874909</ArticleId><ArticleId IdType="pubmed">33713619</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y., Li X., Geng D., Mei N., Wu P.Y., Huang C.C., et al. Cerebral micro-structural changes in COVID-19 patients - an MRI-based 3-month follow-up study. EClinicalMedicine. 2020;25</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7396952</ArticleId><ArticleId IdType="pubmed">32838240</ArticleId></ArticleIdList></Reference><Reference><Citation>Ly M., Raji C.A., Yu G.Z., Wang Q., Wang Y., Schindler S.E., et al. Obesity and white matter neuroinflammation related edema in Alzheimer's disease dementia biomarker negative cognitively normal individuals. J Alzheimers Dis. 2021;79(4):1801&#x2013;1811.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8817782</ArticleId><ArticleId IdType="pubmed">33459647</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y., Deng J., Liu Q., Du M., Liu M., Liu J. Long-term consequences of COVID-19 at 6 Months and above: a systematic review and meta-analysis. Int. J. Environ. Res. Publ. Health. 2022;19(11):6865.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9180091</ArticleId><ArticleId IdType="pubmed">35682448</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahat R.K., Panda S., Rathore V., Swain S., Yadav L., Sah S.P. The dynamics of inflammatory markers in coronavirus disease-2019 (COVID-19) patients: a systematic review and meta-analysis. Clinical Epidemiology and Global Health. 2021;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7979575</ArticleId><ArticleId IdType="pubmed">33778183</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik P., Patel K., Pinto C., Jaiswal R., Tirupathi R., Pillai S., et al. Post-acute COVID-19 syndrome (PCS) and health-related quality of life (HRQoL)&#x2014;a systematic review and meta-analysis. J. Med. Virol. 2022;94(1):253&#x2013;262.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8662132</ArticleId><ArticleId IdType="pubmed">34463956</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza M.G., Palladini M., De Lorenzo R., Magnaghi C., Poletti S., Furlan R., et al. Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: effect of inflammatory biomarkers at three-month follow-up. Brain Behav. Immun. 2021;94:138&#x2013;147.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7903920</ArticleId><ArticleId IdType="pubmed">33639239</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazziotta J., Toga A., Evans A., Fox P., Lancaster J., Zilles K., et al. A probabilistic atlas and reference system for the human brain: international Consortium for Brain Mapping (ICBM) Philos. Trans. R. Soc. Lond. B Biol. Sci. 2001;356(1412):1293&#x2013;1322.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1088516</ArticleId><ArticleId IdType="pubmed">11545704</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehandru S., Merad M. Pathological sequelae of long-haul COVID. Nat. Immunol. 2022;23(2):194&#x2013;202.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9127978</ArticleId><ArticleId IdType="pubmed">35105985</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J., Radke J., Dittmayer C., Franz J., Thomas C., Mothes R., et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat. Neurosci. 2021;24(2):168&#x2013;175.</Citation><ArticleIdList><ArticleId IdType="pubmed">33257876</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad M., Martin J.C. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat. Rev. Immunol. 2020;20(6):355&#x2013;362.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7201395</ArticleId><ArticleId IdType="pubmed">32376901</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller K.L., Alfaro-Almagro F., Bangerter N.K., Thomas D.L., Yacoub E., Xu J., et al. Multimodal population brain imaging in the UK Biobank prospective epidemiological study. Nat. Neurosci. 2016;19(11):1523&#x2013;1536.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5086094</ArticleId><ArticleId IdType="pubmed">27643430</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohandas S., Jagannathan P., Henrich T.J., Sherif Z.A., Bime C., Quinlan E., et al. Immune mechanisms underlying COVID-19 pathology and post-acute sequelae of SARS-CoV-2 infection (PASC) Elife. 2023;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10219649</ArticleId><ArticleId IdType="pubmed">37233729</ArticleId></ArticleIdList></Reference><Reference><Citation>Monje M., Iwasaki A. The neurobiology of long COVID. Neuron. 2022;110(21):3484&#x2013;3496.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9537254</ArticleId><ArticleId IdType="pubmed">36288726</ArticleId></ArticleIdList></Reference><Reference><Citation>Naseer S., Khalid S., Parveen S., Abbass K., Song H., Achim M.V. COVID-19 outbreak: impact on global economy. Front. Public Health. 2022;10</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9923118</ArticleId><ArticleId IdType="pubmed">36793360</ArticleId></ArticleIdList></Reference><Reference><Citation>Netland J., Meyerholz D.K., Moore S., Cassell M., Perlman S. Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J. Virol. 2008;82(15):7264&#x2013;7275.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2493326</ArticleId><ArticleId IdType="pubmed">18495771</ArticleId></ArticleIdList></Reference><Reference><Citation>Parsons N., Outsikas A., Parish A., Clohesy R., D'Aprano F., Toomey F., et al. Modelling the anatomic distribution of neurologic events in patients with COVID-19: a systematic review of MRI findings. AJNR Am J Neuroradiol. 2021;42(7):1190&#x2013;1195.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8324279</ArticleId><ArticleId IdType="pubmed">33888458</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasternak O., Shenton M.E., Westin C.F. Estimation of extracellular volume from regularized multi-shell diffusion MRI. Med Image Comput Comput Assist Interv. 2012;15(0 2):305&#x2013;312.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4039075</ArticleId><ArticleId IdType="pubmed">23286062</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen M., N&#xe4;gele F.L., Mayer C., Schell M., Petersen E., K&#xfc;hn S., et al. Brain imaging and neuropsychological assessment of individuals recovered from a mild to moderate SARS-CoV-2 infection. Proc. Natl. Acad. Sci. U.S.A. 2023;120(22)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10235949</ArticleId><ArticleId IdType="pubmed">37220275</ArticleId></ArticleIdList></Reference><Reference><Citation>Philippens I.H.C.H.M., B&#xf6;sz&#xf6;rm&#xe9;nyi K.P., Wubben J.A., Fagrouch Z.C., Driel N van, Mayenburg A.Q., et al. Brain Inflammation and Intracellular &#x3b1;-Synuclein Aggregates in Macaques after SARS-CoV-2 Infection. Viruses. 2022;14(4):776.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9025893</ArticleId><ArticleId IdType="pubmed">35458506</ArticleId></ArticleIdList></Reference><Reference><Citation>Pines A.R., Cieslak M., Larsen B., Baum G.L., Cook P.A., Adebimpe A., et al. Leveraging multi-shell diffusion for studies of brain development in youth and young adulthood. Dev Cogn Neurosci. 2020;43</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7200217</ArticleId><ArticleId IdType="pubmed">32510347</ArticleId></ArticleIdList></Reference><Reference><Citation>Plantone D., Locci S., Bergantini L., Manco C., Cortese R., Meocci M., et al. Brain neuronal and glial damage during acute COVID-19 infection in absence of clinical neurological manifestations. J. Neurol. Neurosurg. Psychiatry. 2022;93(12):1343&#x2013;1348.</Citation><ArticleIdList><ArticleId IdType="pubmed">36137741</ArticleId></ArticleIdList></Reference><Reference><Citation>Premraj L., Kannapadi N.V., Briggs J., Seal S.M., Battaglini D., Fanning J., et al. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: a meta-analysis. J. Neurol. Sci. 2022;434</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8798975</ArticleId><ArticleId IdType="pubmed">35121209</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabaan A.A., Al-Ahmed S.H., Muhammad J., Khan A., Sule A.A., Tirupathi R., et al. Role of inflammatory cytokines in COVID-19 patients: a review on molecular mechanisms, immune functions, immunopathology and immunomodulatory drugs to counter cytokine storm. Vaccines (Basel) 2021;9(5):436.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8145892</ArticleId><ArticleId IdType="pubmed">33946736</ArticleId></ArticleIdList></Reference><Reference><Citation>Radmanesh A., Derman A., Lui Y.W., Raz E., Loh J.P., Hagiwara M., et al. COVID-19&#x2013;associated diffuse leukoencephalopathy and microhemorrhages. Radiology. 2020;297(1):E223&#x2013;E227.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7507998</ArticleId><ArticleId IdType="pubmed">32437314</ArticleId></ArticleIdList></Reference><Reference><Citation>Ragab D., Salah Eldin H., Taeimah M., Khattab R., Salem R. The COVID-19 cytokine storm; what we know so far. Front. Immunol. 2020;11:1446.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7308649</ArticleId><ArticleId IdType="pubmed">32612617</ArticleId></ArticleIdList></Reference><Reference><Citation>Rau A., Schroeter N., Blazhenets G., Dressing A., Walter L.I., Kellner E., et al. Widespread white matter oedema in subacute COVID-19 patients with neurological symptoms. Brain. 2022;145(9):3203&#x2013;3213.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9214163</ArticleId><ArticleId IdType="pubmed">35675908</ArticleId></ArticleIdList></Reference><Reference><Citation>Samara A., Murphy T., Strain J., Rutlin J., Sun P., Neyman O., et al. Neuroinflammation and white matter alterations in obesity assessed by diffusion basis spectrum imaging. Front. Hum. Neurosci. 2020;13:464.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6971102</ArticleId><ArticleId IdType="pubmed">31992978</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanabria-Diaz G., Etter M.M., Melie-Garcia L., Lieb J.M., Psychogios M.N., Hutter G., et al. Brain cortical alterations in COVID-19 patients with neurological symptoms. Front. Neurosci. 2022;16</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9630324</ArticleId><ArticleId IdType="pubmed">36340780</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwabenland M., Sali&#xe9; H., Tanevski J., Killmer S., Lago M.S., Schlaak A.E., et al. Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions. Immunity. 2021;54(7) 1594-1610.e11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8188302</ArticleId><ArticleId IdType="pubmed">34174183</ArticleId></ArticleIdList></Reference><Reference><Citation>Shirani A., Sun P., Schmidt R.E., Trinkaus K., Naismith R.T., Song S.K., et al. Histopathological correlation of diffusion basis spectrum imaging metrics of a biopsy-proven inflammatory demyelinating brain lesion: a brief report. Mult. Scler. 2019;25(14):1937&#x2013;1941.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7493817</ArticleId><ArticleId IdType="pubmed">29992856</ArticleId></ArticleIdList></Reference><Reference><Citation>Shirani A., Sun P., Trinkaus K., Perantie D.C., George A., Naismith R.T., et al. Diffusion basis spectrum imaging for identifying pathologies in MS subtypes. Ann Clin Transl Neurol. 2019;6(11):2323&#x2013;2327.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6856605</ArticleId><ArticleId IdType="pubmed">31588688</ArticleId></ArticleIdList></Reference><Reference><Citation>Sidhwani S.K., Mirza T., Khatoon A., Shaikh F., Khan R., Shaikh O.A., et al. Inflammatory markers and COVID-19 disease progression. J Infect Public Health. 2023;16(9):1386&#x2013;1391.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10290960</ArticleId><ArticleId IdType="pubmed">37442012</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith S.M., Nichols T.E. Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference. Neuroimage. 2009;44(1):83&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">18501637</ArticleId></ArticleIdList></Reference><Reference><Citation>Soltani Zangbar H., Gorji A., Ghadiri T. A review on the neurological manifestations of COVID-19 infection: a mechanistic view. Mol. Neurobiol. 2021;58(2):536&#x2013;549.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7519857</ArticleId><ArticleId IdType="pubmed">32981023</ArticleId></ArticleIdList></Reference><Reference><Citation>Spudich S., Nath A. Nervous system consequences of COVID-19. Science. 2022;375(6578):267&#x2013;269.</Citation><ArticleIdList><ArticleId IdType="pubmed">35050660</ArticleId></ArticleIdList></Reference><Reference><Citation>Ssentongo P., Ssentongo A.E., Voleti N., Groff D., Sun A., Ba D.M., et al. SARS-CoV-2 vaccine effectiveness against infection, symptomatic and severe COVID-19: a systematic review and meta-analysis. BMC Infect. Dis. 2022;22(1):439.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9077344</ArticleId><ArticleId IdType="pubmed">35525973</ArticleId></ArticleIdList></Reference><Reference><Citation>Stamatovic S.M., Dimitrijevic O.B., Keep R.F., Andjelkovic A.V. Inflammation and brain edema: new insights into the role of chemokines and their receptors. Acta Neurochir. Suppl. 2006;96:444&#x2013;450.</Citation><ArticleIdList><ArticleId IdType="pubmed">16671502</ArticleId></ArticleIdList></Reference><Reference><Citation>Steardo L., Steardo L., Scuderi C. Astrocytes and the psychiatric sequelae of COVID-19: what we learned from the pandemic. Neurochem. Res. 2023;48(4):1015&#x2013;1025.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9362636</ArticleId><ArticleId IdType="pubmed">35922744</ArticleId></ArticleIdList></Reference><Reference><Citation>Strain J.F., Burdo T.H., Song S.K., Sun P., El-Ghazzawy O., Nelson B., et al. Diffusion basis spectrum imaging detects ongoing brain inflammation in virologically well controlled HIV+ patients. J. Acquir. Immune Defic. Syndr. 2017;76(4):423&#x2013;430.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5659935</ArticleId><ArticleId IdType="pubmed">28796748</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudlow C., Gallacher J., Allen N., Beral V., Burton P., Danesh J., et al. UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12(3)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4380465</ArticleId><ArticleId IdType="pubmed">25826379</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun P., George A., Perantie D.C., Trinkaus K., Ye Z., Naismith R.T., et al. Diffusion basis spectrum imaging provides insights into MS pathology. Neurology - Neuroimmunology Neuroinflammation. 2020;7(2)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7011117</ArticleId><ArticleId IdType="pubmed">31871296</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Z., Wu W., Xu H., Flores S., Hobbs D.A., Perrin R.J., et al.   ALZ; 2023. Imaging and Quantifying Microglial Activation in Vivo and Ex Vivo Using Diffusion MRI &#x2013; with Validation by Immunohistochemistry.https://alz.confex.com/alz/2023/meetingapp.cgi/Paper/79302 [cited 2023 Sep 6]. Available from:</Citation></Reference><Reference><Citation>Vanderheiden A., Klein R.S. Neuroinflammation and COVID-19. Curr. Opin. Neurobiol. 2022;76</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9239981</ArticleId><ArticleId IdType="pubmed">35863101</ArticleId></ArticleIdList></Reference><Reference><Citation>VanElzakker M.B., Bues H.F., Brusaferri L., Kim M., Saadi D., Ratai E.M., et al. Neuroinflammation in post-acute sequelae of COVID-19 (PASC) as assessed by [11C]PBR28 PET correlates with vascular disease measures. bioRxiv. 2023:2023.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11225883</ArticleId><ArticleId IdType="pubmed">38642615</ArticleId></ArticleIdList></Reference><Reference><Citation>Vavasour I., Sun P., Graf C., Yik J., Kolind S., Li D., et al. Characterisation of multiple sclerosis neuroinflammation and neurodegeneration with relaxation and diffusion basis spectrum imaging. Mult. Scler. 2022;28(3):418&#x2013;428.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9665421</ArticleId><ArticleId IdType="pubmed">34132126</ArticleId></ArticleIdList></Reference><Reference><Citation>Visser, D., Golla, S.S.V., Verfaillie, S.C.J., Coomans, E.M., Rikken, R.M., Giessen, EM van de, et al., 2022. Long COVID is associated with extensive in-vivo neuroinflammation on [18F]DPA-714 PET. medRxiv [Preprint]. June 04, 2022. [cited 2022 Nov 1]. Available from: https://www.medrxiv.org/content/10.1101/2022.06.02.22275916v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.06.02.22275916v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Wang Q., Haldar J.P., Yeh F.C., Xie M., Sun P., et al. Quantification of increased cellularity during inflammatory demyelination. Brain. 2011;134(12):3590&#x2013;3601.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3235568</ArticleId><ArticleId IdType="pubmed">22171354</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Cusick M.F., Wang Y., Sun P., Libbey J.E., Trinkaus K., et al. Diffusion basis spectrum imaging detects and distinguishes coexisting subclinical inflammation, demyelination and axonal injury in experimental autoimmune encephalomyelitis mice. NMR Biomed. 2014;27(7):843&#x2013;852.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4071074</ArticleId><ArticleId IdType="pubmed">24816651</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Sun P., Wang Q., Trinkaus K., Schmidt R.E., Naismith R.T., et al. Differentiation and quantification of inflammation, demyelination and axon injury or loss in multiple sclerosis. Brain. 2015;138(Pt 5):1223&#x2013;1238.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4407189</ArticleId><ArticleId IdType="pubmed">25724201</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Pathak S., Stefaneanu L., Yeh F.C., Li S., Fernandez-Miranda J.C. Subcomponents and connectivity of the superior longitudinal fasciculus in the human brain. Brain Struct. Funct. 2016;221(4):2075&#x2013;2092.</Citation><ArticleIdList><ArticleId IdType="pubmed">25782434</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q., Wang Y., Liu J., Sutphen C.L., Cruchaga C., Blazey T., et al. Quantification of white matter cellularity and damage in preclinical and early symptomatic Alzheimer's disease. Neuroimage Clin. 2019;22</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6428957</ArticleId><ArticleId IdType="pubmed">30901713</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S., Quan L., Chavarro J.E., Slopen N., Kubzansky L.D., Koenen K.C., et al. Associations of depression, anxiety, worry, perceived stress, and loneliness prior to infection with risk of post&#x2013;COVID-19 conditions. JAMA Psychiatr. 2022;79(11):1081&#x2013;1091.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9453634</ArticleId><ArticleId IdType="pubmed">36069885</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkler A.M., Ridgway G.R., Webster M.A., Smith S.M., Nichols T.E. Permutation inference for the general linear model. Neuroimage. 2014;92(100):381&#x2013;397.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4010955</ArticleId><ArticleId IdType="pubmed">24530839</ArticleId></ArticleIdList></Reference><Reference><Citation>Wischmann J., Bartos L.M., Brendel M., Albert N.L., Forbrig R., Straube A., et al. Translocator protein (TSPO)-PET as diagnostic and monitoring tool in COVID-19 related MRI-negative brainstem encephalitis: a case report. J. Neurol. 2023;270(6):2853&#x2013;2856.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10069725</ArticleId><ArticleId IdType="pubmed">37012466</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodruff M.C., Nguyen D.C., Faliti C.E., Saini A.S., Lee F.E.H., Sanz I. Response under pressure: deploying emerging technologies to understand B-cell-mediated immunity in COVID-19. Nat. Methods. 2022;19(4):387&#x2013;391.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9703369</ArticleId><ArticleId IdType="pubmed">35396475</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu W., Wang Q., Sun Z., Flores S., Hobbs D.A., Franklin E.E., et al. Initial correlation analysis of diffusion basis spectrum imaging of Alzheimer's brain and quantitative histology. Alzheimer's Dementia. 2022;18(S6)</Citation></Reference><Reference><Citation>Xiao L.N., Ran X., Zhong Y.X., Li S.S. Clinical value of blood markers to assess the severity of coronavirus disease 2019. BMC Infect. Dis. 2021;21(1):921.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8420143</ArticleId><ArticleId IdType="pubmed">34488665</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang A.C., Kern F., Losada P.M., Agam M.R., Maat C.A., Schmartz G.P., et al. Dysregulation of brain and choroid plexus cell types in severe COVID-19. Nature. 2021;595(7868):565&#x2013;571.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8400927</ArticleId><ArticleId IdType="pubmed">34153974</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye Z., George A., Wu A.T., Niu X., Lin J., Adusumilli G., et al. Deep learning with diffusion basis spectrum imaging for classification of multiple sclerosis lesions. Ann Clin Transl Neurol. 2020;7(5):695&#x2013;706.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7261762</ArticleId><ArticleId IdType="pubmed">32304291</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhan J., Lin T.H., Libbey J.E., Sun P., Ye Z., Song C., et al. Diffusion basis spectrum and diffusion tensor imaging detect hippocampal inflammation and dendritic injury in a virus-induced mouse model of epilepsy. Front. Neurosci. 2018;12:77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5818459</ArticleId><ArticleId IdType="pubmed">29497358</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W., Rutlin J., Eisenstein S.A., Wang Y., Barch D., Hershey T., et al. Neuroinflammation in the amygdala is associated with recent depressive symptoms. Biol. Psychiatr.: Cognitive Neuroscience and Neuroimaging 8(9), 967-975. 2023</Citation><ArticleIdList><ArticleId IdType="pubmed">37164312</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou S., Wei T., Liu X., Liu Y., Song W., Que X., et al. Causal effects of COVID-19 on structural changes in specific brain regions: a Mendelian randomization study. BMC Med. 2023;21(1):261.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10354891</ArticleId><ArticleId IdType="pubmed">37468885</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>